Cargando…

Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study

BACKGROUND: Spontaneous pneumothorax has a high incidence and high rate of recurrence in patients with lymphangioleiomyomatosis (LAM). The risk factors for pneumothorax and the effects of sirolimus on pneumothorax in patients with LAM are unknown. In our study, multivariate logistic regression was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Chongsheng, Xu, Wenshuai, Wang, Yani, Zhang, Tengyue, Yang, Luning, Zhou, Wangji, Hu, Danjing, Yang, Yanli, Tian, Xinlun, Xu, Kai-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264575/ https://www.ncbi.nlm.nih.gov/pubmed/35804431 http://dx.doi.org/10.1186/s13023-022-02418-2

Ejemplares similares

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis
por: Hu, Siqi, et al.
Publicado: (2019)

Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study
por: Zhan, Yongzhong, et al.
Publicado: (2018)

Gene mutations in sporadic lymphangioleiomyomatosis and genotype–phenotype correlation analysis
por: Huang, Jiannan, et al.
Publicado: (2022)

The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis
por: Xu, Wenshuai, et al.
Publicado: (2021)

Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
por: Zhou, Li, et al.
Publicado: (2018)

Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM)
por: Shen, Lisha, et al.
Publicado: (2021)

Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax
por: Odak, Mihir, et al.
Publicado: (2020)

Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Sakurai, Teiko, et al.
Publicado: (2021)

Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
por: Verma, Ajay Kumar, et al.
Publicado: (2018)

The efficacy and adverse events of mTOR inhibitors in lymphangioleiomyomatosis: systematic review and meta-analysis
por: Gao, Nannan, et al.
Publicado: (2018)

Recent advances in the management of lymphangioleiomyomatosis
por: Xu, Kai-Feng, et al.
Publicado: (2018)

Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study
por: Duan, Chuanxin, et al.
Publicado: (2023)

Effects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
por: Aghaeimeybodi, Fatemeh, et al.
Publicado: (2019)

Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Unexpected sirolimus-stimulated airway hyperreactivity in lymphangioleiomyomatosis
por: Steagall, Wendy K., et al.
Publicado: (2023)

A Total Pleural Covering for Lymphangioleiomyomatosis Prevents Pneumothorax Recurrence
por: Kurihara, Masatoshi, et al.
Publicado: (2016)

The etiology of diffuse cystic lung diseases: an analysis of 1010 consecutive cases in a LAM clinic
por: Cui, Han, et al.
Publicado: (2021)

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis
por: Gonano, Cynthia, et al.
Publicado: (2018)

Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis?
por: Neurohr, Claus, et al.
Publicado: (2011)

Sirolimus in lymphangioleiomyomatosis: A case in point for research in ‘orphan’ diseases
por: Koul, Parvaiz A, et al.
Publicado: (2019)

Spontaneous Pneumothorax in a Young Female With Lymphangioleiomyomatosis
por: Ukponmwan, Osato, et al.
Publicado: (2023)

Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis
por: Namba, Masashi, et al.
Publicado: (2017)

Successful treatment of a patient with chyluria due to lymphangioleiomyomatosis using sirolimus
por: Sakaue, Takahiko, et al.
Publicado: (2018)

Successful Sirolimus Treatment of Lymphangioleiomyomatosis in a Hepatitis B Virus Carrier
por: Sonobe, Shoko, et al.
Publicado: (2018)

Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus
por: Ko, Yuki, et al.
Publicado: (2020)

Pneumothorax as a Presentation of Tuberous Sclerosis-Associated Lymphangioleiomyomatosis
por: Silva, Duarte Lages, et al.
Publicado: (2019)

Probability of sporadic lymphangioleiomyomatosis in women presenting with spontaneous pneumothorax
por: Suter, Audrey, et al.
Publicado: (2023)

Effects of yoga on exercise capacity in patients with lymphangioleiomyomatosis: a nonrandomized controlled study
por: Li, Xiangfeng, et al.
Publicado: (2020)

The effects of total pleural covering on pneumothorax recurrence and pulmonary function in lymphangioleiomyomatosis patients without history of pleurodesis or thoracic surgeries for pneumothorax
por: Suzuki, Emily, et al.
Publicado: (2021)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
por: Freitas, Carolina Salim Gonçalves, et al.
Publicado: (2015)

Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis
por: Huang, Yen-Lin, et al.
Publicado: (2021)

Expression profiles and potential functions of long noncoding RNAs and mRNAs in autoimmune pulmonary alveolar proteinosis patients
por: Yang, Yanli, et al.
Publicado: (2021)

Lymphangioleiomyomatosis With Atypical Presentation Following Pneumothorax: A Case Report
por: Rodrigues, Rita Q, et al.
Publicado: (2023)

Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort
por: Gopalakrishnan, Vissagan, et al.
Publicado: (2018)

Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience
por: Revilla-López, Eva, et al.
Publicado: (2021)

Clinical and Genetic Comparison of Birt–Hogg–Dubé Syndrome (Hornstein–Knickenberg Syndrome) in Chinese: A Systemic Review of Reported Cases
por: Zhou, Wangji, et al.
Publicado: (2022)

Recurrent Spontaneous Pneumothorax in a 42 Years Old Woman With Pulmonary Lymphangioleiomyomatosis: Insights and Pitfalls of the Surgical Treatment
por: Spiliopoulos, Kyriakos, et al.
Publicado: (2013)

Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need
por: Zhang, Tengyue, et al.
Publicado: (2020)

Ga‐68 EDTA aerosols in evaluation of inhaled‐particle deposition and clearance of obstructive pulmonary diseases: A pilot prospective study compared with Galligas
por: Wang, Shao‐Ting, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_93oudjaljfso4a775tevf0boh7